Syntax Stratified MidCap ETF Rating $44.16 +0.12 (+0.27%) As of 09/27/2024 Add Compare Share Share Ratings Stock AnalysisHoldingsRatingsBuy This Stock Syntax Stratified MidCap ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SMDY Aggregate RatingModerate Buy 2.57Holdings in SMDY have an aggregate rating of Moderate Buy based on 595 analyst ratings issued in the past year covering 48 companies (32.2% of the portfolio).SMDY Aggregate Price Target$44.16High Prediction$44.16Average Prediction$44.16Low Prediction$44.16Holdings in SMDY have an aggregate price target of $44.16 and a range of $44.16 to $44.16 covering 48 companies (32.2% of the portfolio).SMDY Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy34 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Syntax Stratified MidCap ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 48 SMDY Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.82%SMGScotts Miracle-Gro$57.69+5.3%4.5239 of 5 stars2.67$72.33 25.4%6Analyst UpgradeOptions Volume1.64%COTYCoty$5.62+1.8%4.6332 of 5 stars2.58$9.55 70.0%19Analyst Forecast1.37%DOCSDoximity$57.96+2.2%2.577 of 5 stars2.57$64.22 10.8%21Positive News1.35%CIENCiena$65.00+5.6%4.8588 of 5 stars2.79$81.38 25.2%14Analyst RevisionGap Down1.28%FYBRFrontier Communications Parent$36.02+0.4%0.7424 of 5 stars2.08$35.31 -2.0%13Positive News1.28%LITELumentum$66.84+5.1%4.5493 of 5 stars2.67$87.40 30.8%15News CoverageGap Down1.24%HRHealthcare Realty Trust$16.85-0.5%3.3288 of 5 stars2.00$17.00 0.9%5Short Interest ↓Positive News1.18%IRDMIridium Communications$27.05-1.0%4.4943 of 5 stars2.67$36.00 33.1%3Short Interest ↑Positive News0.97%ZDZiff Davis$38.50+2.0%4.1459 of 5 stars2.50$65.67 70.6%6Positive NewsGap Down0.83%DTDynatrace$48.47+1.3%4.8396 of 5 stars2.65$63.35 30.7%23Analyst ForecastOptions VolumeNews CoveragePositive News0.70%OHIOmega Healthcare Investors$37.81-0.7%3.8564 of 5 stars2.33$42.00 11.1%9News CoveragePositive News0.68%ACHCAcadia Healthcare$29.33-2.0%4.6539 of 5 stars2.63$52.19 77.9%8Upcoming EarningsGap Down0.68%QLYSQualys$128.650.0%3.0433 of 5 stars2.00$144.36 12.2%17Analyst ForecastNews Coverage0.68%SBRASabra Health Care REIT$17.33-1.0%2.3357 of 5 stars2.71$19.33 11.6%7News CoveragePositive News0.67%THCTenet Healthcare$137.09+2.8%4.7546 of 5 stars2.89$166.41 21.4%18Analyst Revision0.67%LNWLight & Wonder$91.88+4.6%3.9974 of 5 stars2.79$110.91 20.7%14News CoveragePositive NewsGap Up0.63%ARMKAramark$34.99-0.1%4.4184 of 5 stars2.83$43.42 24.1%12Positive News0.57%TXRHTexas Roadhouse$171.86+1.7%4.1772 of 5 stars2.52$193.36 12.5%23Short Interest ↓Analyst RevisionNews CoveragePositive News0.56%WENWendy's$14.73+0.1%4.6176 of 5 stars2.30$18.08 22.8%20Short Interest ↓0.54%WINGWingstop$236.02-0.2%3.8685 of 5 stars2.73$350.73 48.6%22Analyst Upgrade0.52%UTHRUnited Therapeutics$312.05+1.7%4.7709 of 5 stars2.67$388.25 24.4%12Short Interest ↓News CoveragePositive News0.51%DLBDolby Laboratories$81.20+0.7%4.4759 of 5 stars3.00$100.00 23.2%2News CoveragePositive News0.51%HALOHalozyme Therapeutics$62.99+1.8%4.264 of 5 stars2.60$62.78 -0.3%10Positive News0.51%CRUSCirrus Logic$98.67-1.2%4.3112 of 5 stars2.86$132.86 34.6%7Positive News0.50%LADLithia Motors$305.46+2.9%4.1343 of 5 stars2.64$365.91 19.8%11Analyst RevisionPositive News0.49%POSTPost$115.45-1.4%3.8514 of 5 stars2.83$127.50 10.4%6Analyst Forecast0.49%PAGPenske Automotive Group$149.49+2.1%3.836 of 5 stars2.40$166.25 11.2%5Positive News0.49%EXELExelixis$37.10+2.0%4.536 of 5 stars2.50$37.59 1.3%20Upcoming EarningsAnalyst RevisionPositive News0.48%AMKRAmkor Technology$18.58+2.6%4.9305 of 5 stars2.56$31.50 69.5%9Short Interest ↑High Trading Volume0.47%ILMNIllumina$81.87+4.4%4.7821 of 5 stars2.48$140.90 72.1%21Positive News0.46%BMRNBioMarin Pharmaceutical$68.20+0.4%4.9291 of 5 stars2.71$94.00 37.8%24Analyst DowngradeNews CoveragePositive News0.46%ROIVRoivant Sciences$10.08+2.3%2.4195 of 5 stars3.00$17.10 69.6%6Positive News0.45%ANAutoNation$167.21+1.9%3.4232 of 5 stars2.57$201.86 20.7%70.45%SRPTSarepta Therapeutics$62.41+0.8%4.8299 of 5 stars2.83$164.05 162.9%23Analyst Downgrade0.45%WBSWebster Financial$51.45+1.4%4.9404 of 5 stars2.82$62.92 22.3%11Analyst ForecastNews CoveragePositive News0.45%TOLToll Brothers$106.79+1.4%4.8851 of 5 stars2.60$147.57 38.2%150.45%TMHCTaylor Morrison Home$61.17+0.9%4.2818 of 5 stars2.89$82.43 34.8%9Short Interest ↓Positive News0.45%KBHKB Home$58.89+0.9%4.883 of 5 stars2.23$71.21 20.9%130.44%PRGOPerrigo$27.81+0.4%4.8233 of 5 stars2.25$33.00 18.7%4Short Interest ↓News CoveragePositive News0.43%BRBRBellRing Brands$76.90+2.3%2.6866 of 5 stars2.80$79.13 2.9%15Positive News0.43%ASBAssociated Banc$22.53+1.6%4.7836 of 5 stars2.10$27.11 20.3%10Positive News0.43%RGENRepligen$130.86+1.8%4.7545 of 5 stars2.57$178.64 36.5%14Positive News0.43%MTSIMACOM Technology Solutions$103.75+2.4%3.6975 of 5 stars2.91$131.50 26.7%11Positive NewsGap Down0.42%CYTKCytokinetics$40.56+8.2%4.082 of 5 stars2.94$82.00 102.2%18Insider TradeAnalyst RevisionNews CoveragePositive NewsGap UpHigh Trading Volume0.42%GMEDGlobus Medical$75.42+2.8%4.9681 of 5 stars2.75$97.09 28.7%12Positive News0.42%CNOCNO Financial Group$42.33+0.8%4.0834 of 5 stars2.17$41.00 -3.1%6Analyst ForecastShort Interest ↑News Coverage0.41%SFStifel Financial$96.44+1.7%4.1389 of 5 stars2.25$116.29 20.6%8Analyst ForecastShort Interest ↑News CoveragePositive News0.41%SLABSilicon Laboratories$116.85+2.3%2.3121 of 5 stars2.55$136.20 16.6%11Positive NewsGap Down This page (NYSEARCA:SMDY) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syntax Stratified MidCap ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Syntax Stratified MidCap ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.